A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment

Author:

Mahkro Asya12,Hegemann Inga3,Seiler Elena12,Simionato Greta45,Claveria Viviana6,Bogdanov Nikolay12,Sasselli Clelia3,Torgerson Paul7,Kaestner Lars45,Manz Markus G.3,Goede Jeroen S.38,Gassmann Max12,Bogdanova Anna12ORCID

Affiliation:

1. Red Blood Cell Research Group, Institute of Veterinary Physiology, Vetsuisse FacultyUniversity of Zurich Zurich Switzerland

2. Zurich Center for Integrative Human Physiology (ZIHP)University of Zurich Zurich Switzerland

3. Department of Medical HematologyUniversity Hospital Zurich Zürich Switzerland

4. Theoretical Medicine and BiosciencesSaarland University Homburg Germany

5. Experimental PhysicsSaarland University Saarbrücken Germany

6. Centre de Biochimie Structurale, CNRS UMR 5048, INSERM UMR 1054University of Montpellier Montpellier France

7. Section of EpidemiologyVetsuisse FacultyUniversity of Zurich Zurich Switzerland

8. Division of Medical Oncology and HematologyCantonal Hospital Winterthur Winterthur Switzerland

Funder

FP7 Health

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3